Actively Recruiting
Clinical Investigation of a Novel Spectacle Lens on Slowing Down Juvenile Myopia Progression
Led by Essilor International · Updated on 2025-08-07
35
Participants Needed
1
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this exploratory clinical trial is to evaluate the efficacy and safety of a test spectacle lens (standard single vision lens (SVL) during first year, and standard myopia control lens (MCL) in second year), designed with passive red-light emission, for the control of myopia progression in myopic children age 6 to 11 years old, both male and female, with no systemic or ocular anomalies. The main question it aims to answer is: Does the test spectacle lens designed with passive red-light emission provide significant myopia control effect to children? Researchers will compare the standard SVL designed with passive red-light emission to SVL (first year) and MCL designed with passive red-light emission to MCL (second year) to see if the test spectacle lens work to slow down myopia progression. Participants will: * Wear the study spectacles * Visit Essilor R\&D Centre for follow-up sessions
CONDITIONS
Official Title
Clinical Investigation of a Novel Spectacle Lens on Slowing Down Juvenile Myopia Progression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 6 years or older and less than 11 years at the time of consent
- Corrected spherical equivalent refraction between -0.75 D and -5.00 D
- Astigmatism not more than 2.50 D
- Difference in spherical equivalent refraction between eyes not exceeding 1.00 D
- Best corrected visual acuity of 20/25 or better
- Good general health as known by child and parent/guardian
- Agree to wear spectacles more than 12 hours per day at least 6 days per week
- Willing and able to participate for 2 years and attend scheduled visits
You will not qualify if you...
- Any eye or systemic diseases affecting vision or refraction (e.g., keratoconus, diabetes, Down's syndrome)
- Any binocular vision problems
- Amblyopia
- Use of specialized myopia control treatment in the previous month
- Current use of medications affecting pupil size, focusing, or refraction
- Participation in another clinical study within 30 days before baseline visit
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Essilor R&D Centre Singapore
Singapore, Singapore
Actively Recruiting
Research Team
C
Celine Carimalo
CONTACT
T
Thomas Boudenne
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here